Review




Structured Review

Abcam ab108333
Ab108333, supplied by Abcam, used in various techniques. Bioz Stars score: 98/100, based on 2195 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ab108333/product/Abcam
Average 98 stars, based on 2195 article reviews
ab108333 - by Bioz Stars, 2026-02
98/100 stars

Images



Similar Products

86
Danaher Inc casp8 abcam ab108333 rb
Casp8 Abcam Ab108333 Rb, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/casp8 abcam ab108333 rb/product/Danaher Inc
Average 86 stars, based on 1 article reviews
casp8 abcam ab108333 rb - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

86
Danaher Inc caspase 8 abcam ab108333
Caspase 8 Abcam Ab108333, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caspase 8 abcam ab108333/product/Danaher Inc
Average 86 stars, based on 1 article reviews
caspase 8 abcam ab108333 - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

98
Abcam ab108333
Ab108333, supplied by Abcam, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ab108333/product/Abcam
Average 98 stars, based on 1 article reviews
ab108333 - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

98
Abcam caspase 8 antibody abcam ab108333
Impact of the downregulation of Bax, Bak, <t>caspase-8,</t> caspase-9, and caspase-10 expression on cell apoptosis induced by ZIKV infection. (A) Western blot of the specificity and effect of protein knockdown in siRNA-transfected cells. SY5Y cells were transfected with siRNA for 48 h and then cell lysates were prepared for immunoblot with antibody to Bak, Bax, beta-actin, caspase-8, caspase-9, and caspase-10. siControl: cells transfected with no targeting siRNA. siBax/Bak: cells transfected with both siBax and siBak. (B) ZIKV levels in the siRNA-transfected cells supernatants determined by immunofluorescence focus units assay analysis (FFU). SY5Y cells were transfected with siRNA targets to Bax, Bak, both Bax and Bak (Bax/Bak), caspase-8, caspase-9, and caspase-10. At 48 h posttransfection, cells were infected with ZIKV for another 12 h or 24 h. Cell supernatants were collected and subjected to FFU analysis with ZIKV-E antibody. siControl: cells transfected with no targeting siRNA. (C) Analysis of the impact of ZIKV infection on the viability of siRNA-transfected cells. Cells were transfected with siRNA as described above. At 48 h posttransfection, the cells were infected with ZIKV (MOI = 1) for 24 h and subjected to cell viability analysis by ELISA. Mock: uninfected cells. (D) Analysis of the impact of ZIKV infection on the release Cyt c in siRNA-transfected cells. The release of Cyt c in cytosolic fractions was determined as described in Materials and Methods. Staurosporine: siRNA-transfected cells treated with 30 nM staurosporine for 12 h. (E) Analysis of caspase-3 activity in cells after siRNA transfection and ZIKV infection. Caspase-3 activity was measured as described in Materials and Methods. Cyt c = cytosolic fractions of SY5Y cells incubated with Cyt c (10 μM). Data are from three independent experiments and the results are presented as mean ± SEM. ** indicates a significant difference at P values of 0.02 compared to the control; * indicates a significant difference at P values of 0.05 compared to the control.
Caspase 8 Antibody Abcam Ab108333, supplied by Abcam, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caspase 8 antibody abcam ab108333/product/Abcam
Average 98 stars, based on 1 article reviews
caspase 8 antibody abcam ab108333 - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

98
Abcam caspase8 rabbit abcam ab108333
Impact of the downregulation of Bax, Bak, <t>caspase-8,</t> caspase-9, and caspase-10 expression on cell apoptosis induced by ZIKV infection. (A) Western blot of the specificity and effect of protein knockdown in siRNA-transfected cells. SY5Y cells were transfected with siRNA for 48 h and then cell lysates were prepared for immunoblot with antibody to Bak, Bax, beta-actin, caspase-8, caspase-9, and caspase-10. siControl: cells transfected with no targeting siRNA. siBax/Bak: cells transfected with both siBax and siBak. (B) ZIKV levels in the siRNA-transfected cells supernatants determined by immunofluorescence focus units assay analysis (FFU). SY5Y cells were transfected with siRNA targets to Bax, Bak, both Bax and Bak (Bax/Bak), caspase-8, caspase-9, and caspase-10. At 48 h posttransfection, cells were infected with ZIKV for another 12 h or 24 h. Cell supernatants were collected and subjected to FFU analysis with ZIKV-E antibody. siControl: cells transfected with no targeting siRNA. (C) Analysis of the impact of ZIKV infection on the viability of siRNA-transfected cells. Cells were transfected with siRNA as described above. At 48 h posttransfection, the cells were infected with ZIKV (MOI = 1) for 24 h and subjected to cell viability analysis by ELISA. Mock: uninfected cells. (D) Analysis of the impact of ZIKV infection on the release Cyt c in siRNA-transfected cells. The release of Cyt c in cytosolic fractions was determined as described in Materials and Methods. Staurosporine: siRNA-transfected cells treated with 30 nM staurosporine for 12 h. (E) Analysis of caspase-3 activity in cells after siRNA transfection and ZIKV infection. Caspase-3 activity was measured as described in Materials and Methods. Cyt c = cytosolic fractions of SY5Y cells incubated with Cyt c (10 μM). Data are from three independent experiments and the results are presented as mean ± SEM. ** indicates a significant difference at P values of 0.02 compared to the control; * indicates a significant difference at P values of 0.05 compared to the control.
Caspase8 Rabbit Abcam Ab108333, supplied by Abcam, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caspase8 rabbit abcam ab108333/product/Abcam
Average 98 stars, based on 1 article reviews
caspase8 rabbit abcam ab108333 - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

Image Search Results


Impact of the downregulation of Bax, Bak, caspase-8, caspase-9, and caspase-10 expression on cell apoptosis induced by ZIKV infection. (A) Western blot of the specificity and effect of protein knockdown in siRNA-transfected cells. SY5Y cells were transfected with siRNA for 48 h and then cell lysates were prepared for immunoblot with antibody to Bak, Bax, beta-actin, caspase-8, caspase-9, and caspase-10. siControl: cells transfected with no targeting siRNA. siBax/Bak: cells transfected with both siBax and siBak. (B) ZIKV levels in the siRNA-transfected cells supernatants determined by immunofluorescence focus units assay analysis (FFU). SY5Y cells were transfected with siRNA targets to Bax, Bak, both Bax and Bak (Bax/Bak), caspase-8, caspase-9, and caspase-10. At 48 h posttransfection, cells were infected with ZIKV for another 12 h or 24 h. Cell supernatants were collected and subjected to FFU analysis with ZIKV-E antibody. siControl: cells transfected with no targeting siRNA. (C) Analysis of the impact of ZIKV infection on the viability of siRNA-transfected cells. Cells were transfected with siRNA as described above. At 48 h posttransfection, the cells were infected with ZIKV (MOI = 1) for 24 h and subjected to cell viability analysis by ELISA. Mock: uninfected cells. (D) Analysis of the impact of ZIKV infection on the release Cyt c in siRNA-transfected cells. The release of Cyt c in cytosolic fractions was determined as described in Materials and Methods. Staurosporine: siRNA-transfected cells treated with 30 nM staurosporine for 12 h. (E) Analysis of caspase-3 activity in cells after siRNA transfection and ZIKV infection. Caspase-3 activity was measured as described in Materials and Methods. Cyt c = cytosolic fractions of SY5Y cells incubated with Cyt c (10 μM). Data are from three independent experiments and the results are presented as mean ± SEM. ** indicates a significant difference at P values of 0.02 compared to the control; * indicates a significant difference at P values of 0.05 compared to the control.

Journal: Journal of Virology

Article Title: Zika Virus Infection Induced Apoptosis by Modulating the Recruitment and Activation of Proapoptotic Protein Bax

doi: 10.1128/JVI.01445-20

Figure Lengend Snippet: Impact of the downregulation of Bax, Bak, caspase-8, caspase-9, and caspase-10 expression on cell apoptosis induced by ZIKV infection. (A) Western blot of the specificity and effect of protein knockdown in siRNA-transfected cells. SY5Y cells were transfected with siRNA for 48 h and then cell lysates were prepared for immunoblot with antibody to Bak, Bax, beta-actin, caspase-8, caspase-9, and caspase-10. siControl: cells transfected with no targeting siRNA. siBax/Bak: cells transfected with both siBax and siBak. (B) ZIKV levels in the siRNA-transfected cells supernatants determined by immunofluorescence focus units assay analysis (FFU). SY5Y cells were transfected with siRNA targets to Bax, Bak, both Bax and Bak (Bax/Bak), caspase-8, caspase-9, and caspase-10. At 48 h posttransfection, cells were infected with ZIKV for another 12 h or 24 h. Cell supernatants were collected and subjected to FFU analysis with ZIKV-E antibody. siControl: cells transfected with no targeting siRNA. (C) Analysis of the impact of ZIKV infection on the viability of siRNA-transfected cells. Cells were transfected with siRNA as described above. At 48 h posttransfection, the cells were infected with ZIKV (MOI = 1) for 24 h and subjected to cell viability analysis by ELISA. Mock: uninfected cells. (D) Analysis of the impact of ZIKV infection on the release Cyt c in siRNA-transfected cells. The release of Cyt c in cytosolic fractions was determined as described in Materials and Methods. Staurosporine: siRNA-transfected cells treated with 30 nM staurosporine for 12 h. (E) Analysis of caspase-3 activity in cells after siRNA transfection and ZIKV infection. Caspase-3 activity was measured as described in Materials and Methods. Cyt c = cytosolic fractions of SY5Y cells incubated with Cyt c (10 μM). Data are from three independent experiments and the results are presented as mean ± SEM. ** indicates a significant difference at P values of 0.02 compared to the control; * indicates a significant difference at P values of 0.05 compared to the control.

Article Snippet: Caspase-3 activity assay kit, caspase-9 activity assay kit, and Annexin V-FITC were obtained from Biyotime, China. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibodies/reagents Source Identifier Working dilutions Caspase-3 antibody CST #9662S 1:2,000 (WB) Cleaved-caspase-3 antibody CST #9661 1:500 (IF); 1:2,000 (WB) Caspase-8 antibody Abcam Ab108333 1:2,000 (WB) Caspase-9 antibody Abcam Ab32539 1:2,000 (WB) Caspase-10 antibody Abcam Ab32155 1:2,000 (WB) Bcl-X L antibody CST #2764 1:2,000 (WB) BSA antibody CST #66271 1:2,000 (WB) Cyt c antibody CST #11940 1:2,000 (WB) Flag antibody Santa Cruz Ab205606 1:4,000 (WB) Bak antibody Santa Cruz SC518110 1:500 (WB) Bak (Ab-1, clone TC-100) antibody Merck AM03 1:500 (F) Beta-actin antibody Santa Cruz SC8432 1:4,000 (WB) Cox IV antibody CST #4850 1:200 Bax (6A7) antibody Santa Cruz SC23959 1:200 (IP); 1:500 (F) HRP-conjugated anti-rabbit IgG Santa Cruz SC2004 1:1,000 (WB) FITC-conjugated anti-rabbit IgG Santa Cruz SC2012 1:1,000 (IF) FITC-conjugated anti-mouse IgG ZSGB-BIO ZF-0312 1:1,000 (IF) HRP-conjugated anti-mouse IgG Santa Cruz SC2010 1:1,000 (WB) zLEHD.Fmk Beyotime C1202 15 μM zDEVD.Fmk Beyotime C1206 25 μM Staurosporine Beyotime S1882 30 nM CICCP Sigma-Aldrich #555-60-2 10 μM Open in a separate window a WB: western blot; IF: immunofluorescence; F: Flow cytometry.

Techniques: Expressing, Infection, Western Blot, Transfection, Immunofluorescence, Enzyme-linked Immunosorbent Assay, Activity Assay, Incubation

Flow cytometry analysis of the impact of Bax, Bak, caspase-8, caspase-9, and caspase-10 downregulation on inner mitochondrial membrane potential of ZIKV-infected cells. Cells were transfected with siRNAs as described above and infected with ZIKV. At 0, 4, 8, 12, 16, 20, and 24 hpi, cells were then stained with TMRE for 10 min at 37°C and subjected to flow cytometry analysis. CICCP, siRNA-transfected cells treated with carbonyl cyanide m-chlorophenyl hydrazine (10 μM). siControl: cells transfected with no targeting siRNA. Control: siRNA-transfected cells without ZIKV infection. siBax/Bak: cells transfected with both siBax and siBak. Data are from three independent experiments and the results are presented as mean ± SEM.

Journal: Journal of Virology

Article Title: Zika Virus Infection Induced Apoptosis by Modulating the Recruitment and Activation of Proapoptotic Protein Bax

doi: 10.1128/JVI.01445-20

Figure Lengend Snippet: Flow cytometry analysis of the impact of Bax, Bak, caspase-8, caspase-9, and caspase-10 downregulation on inner mitochondrial membrane potential of ZIKV-infected cells. Cells were transfected with siRNAs as described above and infected with ZIKV. At 0, 4, 8, 12, 16, 20, and 24 hpi, cells were then stained with TMRE for 10 min at 37°C and subjected to flow cytometry analysis. CICCP, siRNA-transfected cells treated with carbonyl cyanide m-chlorophenyl hydrazine (10 μM). siControl: cells transfected with no targeting siRNA. Control: siRNA-transfected cells without ZIKV infection. siBax/Bak: cells transfected with both siBax and siBak. Data are from three independent experiments and the results are presented as mean ± SEM.

Article Snippet: Caspase-3 activity assay kit, caspase-9 activity assay kit, and Annexin V-FITC were obtained from Biyotime, China. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibodies/reagents Source Identifier Working dilutions Caspase-3 antibody CST #9662S 1:2,000 (WB) Cleaved-caspase-3 antibody CST #9661 1:500 (IF); 1:2,000 (WB) Caspase-8 antibody Abcam Ab108333 1:2,000 (WB) Caspase-9 antibody Abcam Ab32539 1:2,000 (WB) Caspase-10 antibody Abcam Ab32155 1:2,000 (WB) Bcl-X L antibody CST #2764 1:2,000 (WB) BSA antibody CST #66271 1:2,000 (WB) Cyt c antibody CST #11940 1:2,000 (WB) Flag antibody Santa Cruz Ab205606 1:4,000 (WB) Bak antibody Santa Cruz SC518110 1:500 (WB) Bak (Ab-1, clone TC-100) antibody Merck AM03 1:500 (F) Beta-actin antibody Santa Cruz SC8432 1:4,000 (WB) Cox IV antibody CST #4850 1:200 Bax (6A7) antibody Santa Cruz SC23959 1:200 (IP); 1:500 (F) HRP-conjugated anti-rabbit IgG Santa Cruz SC2004 1:1,000 (WB) FITC-conjugated anti-rabbit IgG Santa Cruz SC2012 1:1,000 (IF) FITC-conjugated anti-mouse IgG ZSGB-BIO ZF-0312 1:1,000 (IF) HRP-conjugated anti-mouse IgG Santa Cruz SC2010 1:1,000 (WB) zLEHD.Fmk Beyotime C1202 15 μM zDEVD.Fmk Beyotime C1206 25 μM Staurosporine Beyotime S1882 30 nM CICCP Sigma-Aldrich #555-60-2 10 μM Open in a separate window a WB: western blot; IF: immunofluorescence; F: Flow cytometry.

Techniques: Flow Cytometry, Infection, Transfection, Staining

Reagents and antibodies used in this manuscript a

Journal: Journal of Virology

Article Title: Zika Virus Infection Induced Apoptosis by Modulating the Recruitment and Activation of Proapoptotic Protein Bax

doi: 10.1128/JVI.01445-20

Figure Lengend Snippet: Reagents and antibodies used in this manuscript a

Article Snippet: Caspase-3 activity assay kit, caspase-9 activity assay kit, and Annexin V-FITC were obtained from Biyotime, China. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibodies/reagents Source Identifier Working dilutions Caspase-3 antibody CST #9662S 1:2,000 (WB) Cleaved-caspase-3 antibody CST #9661 1:500 (IF); 1:2,000 (WB) Caspase-8 antibody Abcam Ab108333 1:2,000 (WB) Caspase-9 antibody Abcam Ab32539 1:2,000 (WB) Caspase-10 antibody Abcam Ab32155 1:2,000 (WB) Bcl-X L antibody CST #2764 1:2,000 (WB) BSA antibody CST #66271 1:2,000 (WB) Cyt c antibody CST #11940 1:2,000 (WB) Flag antibody Santa Cruz Ab205606 1:4,000 (WB) Bak antibody Santa Cruz SC518110 1:500 (WB) Bak (Ab-1, clone TC-100) antibody Merck AM03 1:500 (F) Beta-actin antibody Santa Cruz SC8432 1:4,000 (WB) Cox IV antibody CST #4850 1:200 Bax (6A7) antibody Santa Cruz SC23959 1:200 (IP); 1:500 (F) HRP-conjugated anti-rabbit IgG Santa Cruz SC2004 1:1,000 (WB) FITC-conjugated anti-rabbit IgG Santa Cruz SC2012 1:1,000 (IF) FITC-conjugated anti-mouse IgG ZSGB-BIO ZF-0312 1:1,000 (IF) HRP-conjugated anti-mouse IgG Santa Cruz SC2010 1:1,000 (WB) zLEHD.Fmk Beyotime C1202 15 μM zDEVD.Fmk Beyotime C1206 25 μM Staurosporine Beyotime S1882 30 nM CICCP Sigma-Aldrich #555-60-2 10 μM Open in a separate window a WB: western blot; IF: immunofluorescence; F: Flow cytometry.

Techniques: